QuidelOrtho Launches Certified Analyzer Program to Enhance Diagnostic Access in Rural Areas

QuidelOrtho launches Certified Analyzer Program to enhance diagnostic accessibility in rural US areas. The program reconditions VITROS analyzers for smaller healthcare facilities, ensuring cost-effective, reliable testing. Each device undergoes rigorous checks at QuidelOrtho's Rochester facility and comes with a 12-month service warranty. The program aims to broaden access to high-quality diagnostic testing in underserved communities.

QuidelOrtho Corporation, a leading provider of in vitro diagnostics, has recently announced the launch of its Certified Analyzer Program. This initiative aims to expand access to high-quality diagnostic testing in rural and community hospitals across the United States, particularly in facilities with fewer than 100 beds [1][2][3].

The program focuses on reconditioning and certifying VITROS™ analyzers, ensuring cost-effective and reliable testing solutions for smaller healthcare facilities. QuidelOrtho's Rochester facility is responsible for the rigorous certification process, which includes over 140 system checks, functional adjustments, hardware cleaning or replacement, and extensive performance testing [1][2].

The Certified Analyzer Program features certified VITROS XT 7600 and 5600 Integrated Systems, as well as the VITROS 3600 Immunodiagnostic System. These platforms are designed to support community labs running general chemistries, immunoassay tests, and drugs of abuse screening [1][2].

Each certified analyzer comes with a 12-month warranty on service and support, providing healthcare providers with peace of mind and ensuring the reliability of diagnostic results. QuidelOrtho's Senior Vice President, North America, Audra Jones, emphasized that the program's mission is to equip customers with the tools they need to deliver diagnostic excellence to patients, thereby improving accessibility and access to diagnostic solutions in underserved communities [1][2].

This initiative is part of QuidelOrtho's broader commitment to advancing diagnostics and empowering healthcare providers to make informed decisions. The program is expected to have a significant impact on the healthcare landscape, particularly in rural areas where access to advanced diagnostic technologies has traditionally been limited.

References:

[1] https://www.nasdaq.com/press-release/quidelortho-launches-certified-analyzer-program-2025-08-13
[2] https://www.quidelortho.com/global/en/resources/press-releases/quidelortho-launches-certified-analyzer-program
[3] https://www.stocktitan.net/news/QDEL/quidel-ortho-launches-certified-analyzer-06dxmbzxoamp.html